Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
89Bio Inc banner

89Bio Inc
NASDAQ:ETNB

Watchlist Manager
89Bio Inc Logo
89Bio Inc
NASDAQ:ETNB
Watchlist
Price: 14.84 USD
Market Cap: $2.2B
Write Note Create Alert Ask AI

89Bio Inc
Investor Relations

89bio, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in San Francisco, California and currently employs 41 full-time employees. The company went IPO on 2019-11-11. The firm is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The firm's lead product candidate, BIO89-100, a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG). FGF21 is a metabolic hormone that regulates energy expenditure and glucose and lipid metabolism. The firm's subsidiaries include 89Bio Ltd, 89bio Management, Inc. and UAB 89bio Lithuania.

Show more
Loading
ETNB
S&P 500
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Rohan Palekar
CEO & Director
No Bio Available
Mr. Quoc Le-Nguyen
Chief Technical Officer
No Bio Available
Dr. Harry Mansbach M.D.
Chief Medical Officer
No Bio Available
Mr. Ryan Stephen Martins
Chief Financial Officer
No Bio Available
Mr. Francis W. Sarena
Chief Operating Officer
No Bio Available
Mr. Shiva K. Natarajan CPA
Senior Vice President of Finance & Principal Accounting Officer
No Bio Available
Ms. Annie J. Chang M.B.A.
VP of Investor Relations & Corporate Communications
No Bio Available
Ms. Amanda Kurihara
Vice President of People & Culture
No Bio Available
Ms. Melissa Abel
Senior Vice President of Commercial Strategy
No Bio Available
Mr. Paul Shin
Senior Vice President of R&D Operations
No Bio Available

Contacts

Address
CALIFORNIA
San Francisco
142 Sansome Street, Second Floor
Contacts
+14154329270.0
www.89bio.com
sparklesyt

See Also

Summary
ETNB intrinsic value, competitors valuation, and company profile.
DCF Valuation
ETNB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ETNB stock valuation using valuation multiples.
Wall Street Estimates
ETNB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ETNB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 316,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.